English

Eligibility Type 2 Diabetes Mellitus NCT00558883

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
in this study patients with type 2 diabetes are included, who fulfil the following criteria:
Description

Diabetes Mellitus, Non-Insulin-Dependent

Data type

boolean

Alias
UMLS CUI [1]
C0011860
type 2 diabetes by who criteria, aged 30-75
Description

Non-Insulin-Dependent Diabetes Mellitus WHO classification | Age

Data type

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C4267671
UMLS CUI [2]
C0001779
hba1c ≥ 6.5 % < 8.0 % and/or 2h 75 ogtt plasma glucose ≥ 11.1 mmol/l
Description

Glycosylated hemoglobin A | Oral Glucose Tolerance Test Plasma glucose

Data type

boolean

Alias
UMLS CUI [1]
C0019018
UMLS CUI [2,1]
C0029161
UMLS CUI [2,2]
C0455280
fasting leucocytes count ≥ 6.2 gpt/l (median for newly diagnosed type 2 patients in riad) and/or hscrp ≥ 1.0 mg/dl and < 10 mg/dl (earlier 2.8 mg/dl)
Description

White Blood Cell Count procedure Fasting | Diabetes Mellitus, Non-Insulin-Dependent | C-reactive protein; high sensitivity (hsCRP)

Data type

boolean

Alias
UMLS CUI [1,1]
C0023508
UMLS CUI [1,2]
C0015663
UMLS CUI [2]
C0011860
UMLS CUI [3]
C0973334
informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
excluded were patients with one of the following criteria:
Description

Criteria None

Data type

boolean

Alias
UMLS CUI [1,1]
C0243161
UMLS CUI [1,2]
C0549184
contraindication for acarbose
Description

Medical contraindication Acarbose

Data type

boolean

Alias
UMLS CUI [1,1]
C1301624
UMLS CUI [1,2]
C0050393
chronic gastrointestinal disease
Description

Gastrointestinal Disease chronic

Data type

boolean

Alias
UMLS CUI [1,1]
C0017178
UMLS CUI [1,2]
C0205191
prior antidiabetic treatment
Description

Therapeutic procedure Diabetes Mellitus

Data type

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0011849
intake of statins or drugs with antiinflammatory effects
Description

Statins | Anti-Inflammatory Agents

Data type

boolean

Alias
UMLS CUI [1]
C0360714
UMLS CUI [2]
C0003209
acute or chronic inflammatory diseases
Description

Inflammatory disorder | Chronic inflammatory disorder

Data type

boolean

Alias
UMLS CUI [1]
C1290884
UMLS CUI [2]
C1290886
mi or stroke < 6 months before entry
Description

Myocardial Infarction | Cerebrovascular accident

Data type

boolean

Alias
UMLS CUI [1]
C0027051
UMLS CUI [2]
C0038454
immune diseases
Description

Immune System Diseases

Data type

boolean

Alias
UMLS CUI [1]
C0021053
neoplasia
Description

Neoplastic disease

Data type

boolean

Alias
UMLS CUI [1]
C1882062
diseases with acute weight loss
Description

Weight loss Disease

Data type

boolean

Alias
UMLS CUI [1,1]
C1262477
UMLS CUI [1,2]
C0012634
Back to the top of the page

Similar models

Eligibility Type 2 Diabetes Mellitus NCT00558883

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Diabetes Mellitus, Non-Insulin-Dependent
Item
in this study patients with type 2 diabetes are included, who fulfil the following criteria:
boolean
C0011860 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus WHO classification | Age
Item
type 2 diabetes by who criteria, aged 30-75
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0001779 (UMLS CUI [2])
Glycosylated hemoglobin A | Oral Glucose Tolerance Test Plasma glucose
Item
hba1c ≥ 6.5 % < 8.0 % and/or 2h 75 ogtt plasma glucose ≥ 11.1 mmol/l
boolean
C0019018 (UMLS CUI [1])
C0029161 (UMLS CUI [2,1])
C0455280 (UMLS CUI [2,2])
White Blood Cell Count procedure Fasting | Diabetes Mellitus, Non-Insulin-Dependent | C-reactive protein; high sensitivity (hsCRP)
Item
fasting leucocytes count ≥ 6.2 gpt/l (median for newly diagnosed type 2 patients in riad) and/or hscrp ≥ 1.0 mg/dl and < 10 mg/dl (earlier 2.8 mg/dl)
boolean
C0023508 (UMLS CUI [1,1])
C0015663 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2])
C0973334 (UMLS CUI [3])
Informed Consent
Item
informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Criteria None
Item
excluded were patients with one of the following criteria:
boolean
C0243161 (UMLS CUI [1,1])
C0549184 (UMLS CUI [1,2])
Medical contraindication Acarbose
Item
contraindication for acarbose
boolean
C1301624 (UMLS CUI [1,1])
C0050393 (UMLS CUI [1,2])
Gastrointestinal Disease chronic
Item
chronic gastrointestinal disease
boolean
C0017178 (UMLS CUI [1,1])
C0205191 (UMLS CUI [1,2])
Therapeutic procedure Diabetes Mellitus
Item
prior antidiabetic treatment
boolean
C0087111 (UMLS CUI [1,1])
C0011849 (UMLS CUI [1,2])
Statins | Anti-Inflammatory Agents
Item
intake of statins or drugs with antiinflammatory effects
boolean
C0360714 (UMLS CUI [1])
C0003209 (UMLS CUI [2])
Inflammatory disorder | Chronic inflammatory disorder
Item
acute or chronic inflammatory diseases
boolean
C1290884 (UMLS CUI [1])
C1290886 (UMLS CUI [2])
Myocardial Infarction | Cerebrovascular accident
Item
mi or stroke < 6 months before entry
boolean
C0027051 (UMLS CUI [1])
C0038454 (UMLS CUI [2])
Immune System Diseases
Item
immune diseases
boolean
C0021053 (UMLS CUI [1])
Neoplastic disease
Item
neoplasia
boolean
C1882062 (UMLS CUI [1])
Weight loss Disease
Item
diseases with acute weight loss
boolean
C1262477 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
Back to the top of the page